-The Times of India NEW DELHI: The government on Friday refused to yield to pressure from developed countries to accept easier customs rules without its food subsidy concerns being addressed, putting at risk a likely deal at the World Trade Organization (WTO). Developed countries have stepped up the pressure on India saying failure to strike a deal on trade facilitation would stall global trade reforms and deal a massive blow to the...

-Down to Earth One-third of India's population are migrants, but the country is yet to make a policy or plan for them, says collaborative study report by Institute of Social Sciences and UNICEF As many as 309 million people, nearly a third of India's population, were migrants according to the 2001 Census. But the only ‘right' which they are able to exercise is the one that allows all citizens the right to...

-Down to Earth Grand old party of India renews some old promises and makes some new ones, but will Congress live up to its promises if it wins a third term? The Indian National Congress (INC) presented its manifesto for the upcoming Lok Sabha elections on Wedneday. The manifesto committee claimed the 48-page document was prepared after wide consultations by engaging millions of people, grassroots congress workers and every section of the...

-The Hindu     Genetically modified crops, whose ecological effects are irreversible, could become a mainstay of Indian agriculture thanks to collusion between the government and the biotech industry The final report of the Supreme Court-appointed Technical Expert Committee (TEC) on field trials of genetically modified crops is packed with revelations on what is wrong with institutional governance and regulation in India when it comes to GMOs (genetically-modified organisms). The report's release late last...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...